Medindia LOGIN REGISTER
Medindia

Prednisone Interaction with other Drugs


Prednisone regulates the symptoms of low corticosteroid levels, and is used to treat arthritis, severe allergic reactions, multiple sclerosis, lupus, and certain conditions that affect the lungs, skin, eyes, kidneys blood, thyroid, stomach, and intestines.

Prednisone Interaction with 449 drugs. Find out more in the list below:

4-Phenylbutyric Acid


The therapeutic efficacy of Phenylbutyric acid can be decreased when used in combination with Prednisone.

Acarbose


The therapeutic efficacy of Acarbose can be decreased when used in combination with Prednisone.

Aceclofenac


The risk or severity of adverse effects can be increased when Aceclofenac is combined with Prednisone.

Advertisement

Acemetacin


The risk or severity of adverse effects can be increased when Acemetacin is combined with Prednisone.

Acetohexamide


The therapeutic efficacy of Acetohexamide can be decreased when used in combination with Prednisone.

Acetyl salicylate


The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Prednisone.

Advertisement

Acetyldigitoxin


Acetyldigitoxin may decrease the cardiotoxic activities of Prednisone.

Adapalene


The risk or severity of adverse effects can be increased when Adapalene is combined with Prednisone.

Afatinib


The serum concentration of Afatinib can be increased when it is combined with Prednisone.

Advertisement

Aldesleukin


Prednisone may decrease the antineoplastic activities of Aldesleukin.

Alminoprofen


The risk or severity of adverse effects can be increased when Alminoprofen is combined with Prednisone.

Alogliptin


The therapeutic efficacy of Alogliptin can be decreased when used in combination with Prednisone.

Aloxiprin


The risk or severity of adverse effects can be increased when Aloxiprin is combined with Prednisone.

Aluminum


The bioavailability of Prednisone can be decreased when combined with Aluminium.

Aluminum Hydroxide


The bioavailability of Prednisone can be decreased when combined with Aluminum hydroxide.

aluminum hydroxide, dried (USP)


The bioavailability of Prednisone can be decreased when combined with Aluminum hydroxide.

Aluminum Magnesium Silicate


The bioavailability of Prednisone can be decreased when combined with Almasilate.

Ambenonium


The risk or severity of adverse effects can be increased when Prednisone is combined with Ambenonium.

Aminosalicylic Acid


The risk or severity of adverse effects can be increased when Aminosalicylic Acid is combined with Prednisone.

Amiodarone


The serum concentration of Prednisone can be increased when it is combined with Amiodarone.

Amphotericin B


Prednisone may increase the hypokalemic activities of Amphotericin B.

amphotericin B liposomal


Prednisone may increase the hypokalemic activities of Amphotericin B.

Ancestim


The risk or severity of cytotoxicity can be increased when Ancestim is combined with Prednisone.

Anhydrous Tacrolimus


Tacrolimus may increase the immunosuppressive activities of Prednisone.

Anthrax immune globulin, human


The risk or severity of adverse effects can be increased when Prednisone is combined with Anthrax immune globulin human.

Antipyrine


The risk or severity of adverse effects can be increased when Antipyrine is combined with Prednisone.

Apalutamide


The serum concentration of Prednisone can be decreased when it is combined with Apalutamide.

Apazone


The risk or severity of adverse effects can be increased when Azapropazone is combined with Prednisone.

Apremilast


The risk or severity of adverse effects can be increased when Apremilast is combined with Prednisone.

Aprepitant


The serum concentration of Prednisone can be increased when it is combined with Aprepitant.

Aripiprazole


The serum concentration of Aripiprazole can be decreased when it is combined with Prednisone.

Aspirin


The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Prednisone.

Atazanavir


The serum concentration of Prednisone can be increased when it is combined with Atazanavir.

Atomoxetine


The metabolism of Prednisone can be decreased when combined with Atomoxetine.

Atorvastatin


The risk or severity of adverse effects can be increased when Prednisone is combined with Atorvastatin.

Atracurium Besylate


Atracurium besylate may increase the adverse neuromuscular activities of Prednisone.

Azelastine


The risk or severity of adverse effects can be increased when Azelastine is combined with Prednisone.

Azosemide


Prednisone may increase the hypokalemic activities of Azosemide.

Balsalazide


The risk or severity of adverse effects can be increased when Balsalazide is combined with Prednisone.

BCG Vaccine


The risk or severity of adverse effects can be increased when Prednisone is combined with BCG vaccine.

BCG, Live, Connaught Strain


The risk or severity of adverse effects can be increased when Prednisone is combined with Bacillus calmette-guerin substrain connaught live antigen.

BCG, Live, Tice Strain


The risk or severity of adverse effects can be increased when Prednisone is combined with Bacillus calmette-guerin substrain tice live antigen.

Bendroflumethiazide


Prednisone may increase the hypokalemic activities of Bendroflumethiazide.

Benzoic Acid


The therapeutic efficacy of Benzoic Acid can be decreased when used in combination with Prednisone.

Benzydamine


The risk or severity of adverse effects can be increased when Benzydamine is combined with Prednisone.

Bevacizumab


Bevacizumab may increase the cardiotoxic activities of Prednisone.

Bevacizumab-Awwb


Bevacizumab may increase the cardiotoxic activities of Prednisone.

Bismuth Subcitrate


The bioavailability of Prednisone can be decreased when combined with Bismuth Subcitrate.

Boceprevir


The serum concentration of Prednisone can be increased when it is combined with Boceprevir.

Bortezomib


The metabolism of Prednisone can be decreased when combined with Bortezomib.

Bosentan


The serum concentration of Prednisone can be decreased when it is combined with Bosentan.

Bosutinib


The serum concentration of Bosutinib can be increased when it is combined with Prednisone.

Bosutinib monohydrate


The serum concentration of Bosutinib can be increased when it is combined with Prednisone.

Brentuximab Vedotin


The serum concentration of Brentuximab vedotin can be increased when it is combined with Prednisone.

Bromfenac


The risk or severity of adverse effects can be increased when Bromfenac is combined with Prednisone.

Bromocriptine


The risk or severity of adverse effects can be increased when Bromocriptine is combined with Prednisone.

Bufexamac


The risk or severity of adverse effects can be increased when Bufexamac is combined with Prednisone.

Bumetanide


Prednisone may increase the hypokalemic activities of Bumetanide.

Cabazitaxel


The risk or severity of adverse effects can be increased when Cabazitaxel is combined with Prednisone.

Cabergoline


The risk or severity of adverse effects can be increased when Cabergoline is combined with Prednisone.

Calcitriol


The therapeutic efficacy of Calcitriol can be decreased when used in combination with Prednisone.

Calcium Carbonate


The bioavailability of Prednisone can be decreased when combined with Calcium Carbonate.

CALCIUM CARBONATE, PRECIPITATED


The bioavailability of Prednisone can be decreased when combined with Calcium Carbonate.

Canagliflozin


The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Prednisone.

Canagliflozin Anhydrous


The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Prednisone.

Capromab Pendetide


Prednisone may decrease effectiveness of Capromab pendetide as a diagnostic agent.

Carbamazepine


The serum concentration of Prednisone can be decreased when it is combined with Carbamazepine.

Carprofen


The risk or severity of adverse effects can be increased when Carprofen is combined with Prednisone.

Celecoxib


The risk or severity of adverse effects can be increased when Celecoxib is combined with Prednisone.

Ceritinib


The serum concentration of Prednisone can be increased when it is combined with Ceritinib.

Cerivastatin


The serum concentration of Cerivastatin can be increased when it is combined with Prednisone.

Chloroquine


The risk or severity of adverse effects can be increased when Chloroquine is combined with Prednisone.

Chlorothiazide


Prednisone may increase the hypokalemic activities of Chlorothiazide.

Chlorotrianisene


The serum concentration of Prednisone can be increased when it is combined with Chlorotrianisene.

Chlorpropamide


The therapeutic efficacy of Chlorpropamide can be decreased when used in combination with Prednisone.

Chlorthalidone


Prednisone may increase the hypokalemic activities of Chlorthalidone.

Cholestyramine Resin


Cholestyramine can cause a decrease in the absorption of Prednisone resulting in a reduced serum concentration and potentially a decrease in efficacy.

Choline Magnesium Trisalicyclate


The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with Prednisone.

Cinoxacin


The risk or severity of adverse effects can be increased when Prednisone is combined with Cinoxacin.

Clarithromycin


The serum concentration of Prednisone can be increased when it is combined with Clarithromycin.

Clemastine


The metabolism of Prednisone can be decreased when combined with Clemastine.

Clonixin


The risk or severity of adverse effects can be increased when Clonixin is combined with Prednisone.

Clotrimazole


The metabolism of Prednisone can be decreased when combined with Clotrimazole.

Cobicistat


The serum concentration of Prednisone can be increased when it is combined with Cobicistat.

Colchicine


The serum concentration of Colchicine can be increased when it is combined with Prednisone.

Colesevelam


Colesevelam can cause a decrease in the absorption of Prednisone resulting in a reduced serum concentration and potentially a decrease in efficacy.

Colestipol


Colestipol can cause a decrease in the absorption of Prednisone resulting in a reduced serum concentration and potentially a decrease in efficacy.

Conivaptan


The serum concentration of Conivaptan can be increased when it is combined with Prednisone.

Corticorelin Ovine


The therapeutic efficacy of Corticorelin ovine triflutate can be decreased when used in combination with Prednisone.

Corticorelin Ovine Triflutate


The therapeutic efficacy of Corticorelin ovine triflutate can be decreased when used in combination with Prednisone.

Crizotinib


The metabolism of Prednisone can be decreased when combined with Crizotinib.

Curcumin


The risk or severity of adverse effects can be increased when Curcumin is combined with Prednisone.

Cyclopenthiazide


Prednisone may increase the hypokalemic activities of Cyclopenthiazide.

Cyclophosphamide


Cyclophosphamide may increase the cardiotoxic activities of Prednisone.

Cyclophosphamide Anhydrous


Cyclophosphamide may increase the cardiotoxic activities of Prednisone.

Cyclosporine


The serum concentration of the active metabolites of Prednisone can be increased when Prednisone is used in combination with Cyclosporine.

Dabigatran Etexilate


The serum concentration of the active metabolites of Dabigatran etexilate can be increased when Dabigatran etexilate is used in combination with Prednisone.

Dabrafenib


The serum concentration of Prednisone can be decreased when it is combined with Dabrafenib.

Danazol


Prednisone may increase the fluid retaining activities of Danazol.

Darunavir


The serum concentration of Prednisone can be increased when it is combined with Darunavir.

Dasatinib


The serum concentration of Prednisone can be increased when it is combined with Dasatinib.

Dasatinib Anhydrous


The serum concentration of Prednisone can be increased when it is combined with Dasatinib.

Deferasirox


The serum concentration of Prednisone can be decreased when it is combined with Deferasirox.

Delavirdine


The metabolism of Prednisone can be decreased when combined with Delavirdine.

Demecarium


The risk or severity of adverse effects can be increased when Prednisone is combined with Demecarium.

Denosumab


The risk or severity of adverse effects can be increased when Denosumab is combined with Prednisone.

Deslanoside


Deslanoside may decrease the cardiotoxic activities of Prednisone.

Diclofenac


The risk or severity of adverse effects can be increased when Diclofenac is combined with Prednisone.

Dienestrol


The serum concentration of Prednisone can be increased when it is combined with Dienestrol.

Diethylstilbestrol


The serum concentration of Prednisone can be increased when it is combined with Diethylstilbestrol.

Diflunisal


The risk or severity of adverse effects can be increased when Diflunisal is combined with Prednisone.

Digitoxin


Digitoxin may decrease the cardiotoxic activities of Prednisone.

Digoxin


Digoxin may decrease the cardiotoxic activities of Prednisone.

Dihydroergotamine


The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Prednisone.

Diltiazem


The metabolism of Prednisone can be decreased when combined with Diltiazem.

Dipyrone


The risk or severity of adverse effects can be increased when Metamizole is combined with Prednisone.

Distigmine


The risk or severity of adverse effects can be increased when Prednisone is combined with Distigmine.

Docetaxel


The risk or severity of adverse effects can be increased when Docetaxel is combined with Prednisone.

DOCETAXEL ANHYDROUS


The risk or severity of adverse effects can be increased when Docetaxel is combined with Prednisone.

Donepezil


The risk or severity of adverse effects can be increased when Prednisone is combined with Donepezil.

Doxorubicin


The serum concentration of Doxorubicin can be increased when it is combined with Prednisone.

Doxorubicin Hydrochloride


The serum concentration of Doxorubicin can be increased when it is combined with Prednisone.

Doxycycline


The metabolism of Prednisone can be decreased when combined with Doxycycline.

Doxycycline Anhydrous


The metabolism of Prednisone can be decreased when combined with Doxycycline.

Dronedarone


The metabolism of Prednisone can be decreased when combined with Dronedarone.

Droxicam


The risk or severity of adverse effects can be increased when Droxicam is combined with Prednisone.

Dulaglutide


The therapeutic efficacy of Dulaglutide can be decreased when used in combination with Prednisone.

Echothiophate


The risk or severity of adverse effects can be increased when Prednisone is combined with Echothiophate.

Edoxaban


The serum concentration of Edoxaban can be increased when it is combined with Prednisone.

Edrophonium


The risk or severity of adverse effects can be increased when Prednisone is combined with Edrophonium.

Empagliflozin


The therapeutic efficacy of Empagliflozin can be decreased when used in combination with Prednisone.

Enoxacin


The risk or severity of adverse effects can be increased when Prednisone is combined with Enoxacin.

Enzalutamide


The serum concentration of Prednisone can be decreased when it is combined with Enzalutamide.

Equol, (-)-


The serum concentration of Prednisone can be increased when it is combined with Equol.

Ergonovine


The risk or severity of adverse effects can be increased when Ergonovine is combined with Prednisone.

Ergotamine


The risk or severity of adverse effects can be increased when Ergotamine is combined with Prednisone.

Erythromycin


The metabolism of Prednisone can be decreased when combined with Erythromycin.

Estradiol


The serum concentration of Prednisone can be increased when it is combined with Estradiol.

Estradiol acetate


The serum concentration of Prednisone can be increased when it is combined with Estradiol acetate.

Estradiol Cypionate


The serum concentration of Prednisone can be increased when it is combined with Estradiol cypionate.

Estradiol Valerate


The serum concentration of Prednisone can be increased when it is combined with Estradiol valerate.

Estriol


The serum concentration of Prednisone can be increased when it is combined with Estriol.

Estrogens, Conjugated (USP)


The serum concentration of Prednisone can be increased when it is combined with Conjugated estrogens.

Estrogens, Esterified (USP)


The serum concentration of Prednisone can be increased when it is combined with Estrogens, esterified.

Estrone


The serum concentration of Prednisone can be increased when it is combined with Estrone.

Etanercept


The risk or severity of adverse effects can be increased when Etanercept is combined with Prednisone.

Ethacrynate


Prednisone may increase the hypokalemic activities of Etacrynic acid.

Ethacrynic Acid


Prednisone may increase the hypokalemic activities of Etacrynic acid.

Ethinyl Estradiol


The serum concentration of Prednisone can be increased when it is combined with Ethinyl Estradiol.

Etodolac


The risk or severity of adverse effects can be increased when Etodolac is combined with Prednisone.

Etofenamate


The risk or severity of adverse effects can be increased when Etofenamate is combined with Prednisone.

Etoricoxib


The risk or severity of adverse effects can be increased when Etoricoxib is combined with Prednisone.

Evening primrose oil


The risk or severity of adverse effects can be increased when Evening primrose oil is combined with Prednisone.

Everolimus


The serum concentration of Everolimus can be increased when it is combined with Prednisone.

Exenatide


The therapeutic efficacy of Exenatide can be decreased when used in combination with Prednisone.

Felbinac


The risk or severity of adverse effects can be increased when Felbinac is combined with Prednisone.

Fenbufen


The risk or severity of adverse effects can be increased when Fenbufen is combined with Prednisone.

Fenoprofen


The risk or severity of adverse effects can be increased when Fenoprofen is combined with Prednisone.

Ferulic Acid


The risk or severity of adverse effects can be increased when Ferulic acid is combined with Prednisone.

Fingolimod


Prednisone may increase the immunosuppressive activities of Fingolimod.

Fleroxacin


The risk or severity of adverse effects can be increased when Prednisone is combined with Fleroxacin.

Floctafenine


The risk or severity of adverse effects can be increased when Floctafenine is combined with Prednisone.

Fluconazole


The serum concentration of Prednisone can be increased when it is combined with Fluconazole.

Flumequine


The risk or severity of adverse effects can be increased when Prednisone is combined with Flumequine.

Fluoxymesterone


Prednisone may increase the fluid retaining activities of Fluoxymesterone.

Flurbiprofen


The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Prednisone.

Fluvastatin


The serum concentration of Fluvastatin can be increased when it is combined with Prednisone.

Fluvoxamine


The metabolism of Prednisone can be decreased when combined with Fluvoxamine.

Fosamprenavir


The metabolism of Prednisone can be decreased when combined with Fosamprenavir.

Fosaprepitant


The serum concentration of Prednisone can be increased when it is combined with Fosaprepitant.

Fosphenytoin


The serum concentration of Prednisone can be decreased when it is combined with Fosphenytoin.

Furosemide


Prednisone may increase the hypokalemic activities of Furosemide.

Fusidate


The serum concentration of Prednisone can be increased when it is combined with Fusidic Acid.

Fusidic Acid


The serum concentration of Prednisone can be increased when it is combined with Fusidic Acid.

Galantamine


The risk or severity of adverse effects can be increased when Prednisone is combined with Galantamine.

Gallamine Triethiodide


The risk or severity of adverse effects can be increased when Prednisone is combined with Gallamine Triethiodide.

Gatifloxacin


The risk or severity of adverse effects can be increased when Prednisone is combined with Gatifloxacin.

Gatifloxacin Anhydrous


The risk or severity of adverse effects can be increased when Prednisone is combined with Gatifloxacin.

Gemifloxacin


The risk or severity of adverse effects can be increased when Prednisone is combined with Gemifloxacin.

Gemifloxacin Mesylate


The risk or severity of adverse effects can be increased when Prednisone is combined with Gemifloxacin.

Genistein


The serum concentration of Prednisone can be increased when it is combined with Genistein.

Ginkgo biloba extract


The risk or severity of adverse effects can be increased when Prednisone is combined with Ginkgo biloba.

Glibornuride


The therapeutic efficacy of Glibornuride can be decreased when used in combination with Prednisone.

Gliclazide


The therapeutic efficacy of Gliclazide can be decreased when used in combination with Prednisone.

Glimepiride


The therapeutic efficacy of Glimepiride can be decreased when used in combination with Prednisone.

Glipizide


The therapeutic efficacy of Glipizide can be decreased when used in combination with Prednisone.

Gliquidone


The therapeutic efficacy of Gliquidone can be decreased when used in combination with Prednisone.

Glyburide


The therapeutic efficacy of Glyburide can be decreased when used in combination with Prednisone.

Glycerol Phenylbutyrate


The therapeutic efficacy of Glycerol Phenylbutyrate can be decreased when used in combination with Prednisone.

Grepafloxacin


The risk or severity of adverse effects can be increased when Prednisone is combined with Grepafloxacin.

Hepatitis A Vaccine, Inactivated


The risk or severity of adverse effects can be increased when Prednisone is combined with Hepatitis A Vaccine.

Hepatitis B Surface Antigen Vaccine


The risk or severity of adverse effects can be increased when Prednisone is combined with Hepatitis B Vaccine (Recombinant).

Hyaluronidase


The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Prednisone.

Hyaluronidase, Ovine


The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Prednisone.

Hydrochlorothiazide


Prednisone may increase the hypokalemic activities of Hydrochlorothiazide.

Hydroflumethiazide


Prednisone may increase the hypokalemic activities of Hydroflumethiazide.

Hydrotalcite


The bioavailability of Prednisone can be decreased when combined with Hydrotalcite.

Hypoxis hemerocallidea root extract


The serum concentration of Prednisone can be decreased when it is combined with St. John's Wort.

Ibrutinib


The serum concentration of Ibrutinib can be increased when it is combined with Prednisone.

Ibuprofen


The risk or severity of adverse effects can be increased when Ibuprofen is combined with Prednisone.

Icatibant


The risk or severity of adverse effects can be increased when Icatibant is combined with Prednisone.

Idelalisib


The serum concentration of Prednisone can be increased when it is combined with Idelalisib.

Imatinib


The metabolism of Prednisone can be decreased when combined with Imatinib.

Indacaterol


Indacaterol may increase the hypokalemic activities of Prednisone.

Indapamide


Prednisone may increase the hypokalemic activities of Indapamide.

Indinavir


The serum concentration of Prednisone can be increased when it is combined with Indinavir.

INDINAVIR ANHYDROUS


The serum concentration of Prednisone can be increased when it is combined with Indinavir.

Indobufen


The risk or severity of adverse effects can be increased when Indobufen is combined with Prednisone.

Indomethacin


The risk or severity of adverse effects can be increased when Indomethacin is combined with Prednisone.

Insulin Detemir


The therapeutic efficacy of Insulin Detemir can be decreased when used in combination with Prednisone.

Insulin Glargine


The therapeutic efficacy of Insulin Glargine can be decreased when used in combination with Prednisone.

insulin human, rDNA origin


The therapeutic efficacy of Insulin Human can be decreased when used in combination with Prednisone.

Insulin Lispro


The therapeutic efficacy of Insulin Lispro can be decreased when used in combination with Prednisone.

Insulin, Aspart Protamine, Human


The therapeutic efficacy of Insulin Aspart can be decreased when used in combination with Prednisone.

Insulin, Aspart, Human


The therapeutic efficacy of Insulin Aspart can be decreased when used in combination with Prednisone.

Insulin, Glulisine, Human


The therapeutic efficacy of Insulin Glulisine can be decreased when used in combination with Prednisone.

Insulin, Pork


The therapeutic efficacy of Insulin Pork can be decreased when used in combination with Prednisone.

Insulin, Protamine Lispro, Human


The therapeutic efficacy of Insulin Lispro can be decreased when used in combination with Prednisone.

Insulin, Regular, Pork


The therapeutic efficacy of Insulin Pork can be decreased when used in combination with Prednisone.

Isavuconazole


The serum concentration of Prednisone can be increased when it is combined with Isavuconazole.

Isavuconazonium


The metabolism of Prednisone can be decreased when combined with Isavuconazonium.

Isoflurophate


The risk or severity of adverse effects can be increased when Prednisone is combined with Isoflurophate.

Isoniazid


The serum concentration of Isoniazid can be decreased when it is combined with Prednisone.

Isradipine


The metabolism of Prednisone can be decreased when combined with Isradipine.

Itraconazole


The serum concentration of Prednisone can be increased when it is combined with Itraconazole.

Ivacaftor


The serum concentration of Prednisone can be increased when it is combined with Ivacaftor.

Kebuzone


The risk or severity of adverse effects can be increased when Kebuzone is combined with Prednisone.

Ketoconazole


The serum concentration of Prednisone can be increased when it is combined with Ketoconazole.

Ketoprofen


The risk or severity of adverse effects can be increased when Ketoprofen is combined with Prednisone.

Ketorolac


The risk or severity of adverse effects can be increased when Ketorolac is combined with Prednisone.

Lacidipine


The serum concentration of Lacidipine can be decreased when it is combined with Prednisone.

Ledipasvir


The serum concentration of Ledipasvir can be increased when it is combined with Prednisone.

Leflunomide


The risk or severity of adverse effects can be increased when Prednisone is combined with Leflunomide.

Levofloxacin


The risk or severity of adverse effects can be increased when Prednisone is combined with Levofloxacin.

Levofloxacin Anhydrous


The risk or severity of adverse effects can be increased when Prednisone is combined with Levofloxacin.

Limonene, (+)-


The risk or severity of adverse effects can be increased when (4R)-limonene is combined with Prednisone.

Linagliptin


The therapeutic efficacy of Linagliptin can be decreased when used in combination with Prednisone.

Liraglutide


The therapeutic efficacy of Liraglutide can be decreased when used in combination with Prednisone.

Lisuride


The risk or severity of adverse effects can be increased when Lisuride is combined with Prednisone.

Lopinavir


The serum concentration of Prednisone can be increased when it is combined with Lopinavir.

Lornoxicam


The risk or severity of adverse effects can be increased when Lornoxicam is combined with Prednisone.

Lovastatin


The serum concentration of Lovastatin can be increased when it is combined with Prednisone.

Loxoprofen


The risk or severity of adverse effects can be increased when Loxoprofen is combined with Prednisone.

Luliconazole


The serum concentration of Prednisone can be increased when it is combined with Luliconazole.

Lumacaftor


The serum concentration of Prednisone can be decreased when it is combined with Lumacaftor.

Magaldrate


The bioavailability of Prednisone can be decreased when combined with Magaldrate.

Magnesium Hydroxide


The bioavailability of Prednisone can be decreased when combined with Magnesium hydroxide.

Magnesium Oxide


The bioavailability of Prednisone can be decreased when combined with Magnesium oxide.

Magnesium Salicylate


The risk or severity of adverse effects can be increased when Magnesium salicylate is combined with Prednisone.

Magnesium Trisilicate


The bioavailability of Prednisone can be decreased when combined with Magnesium Trisilicate.

Malathion


The risk or severity of adverse effects can be increased when Prednisone is combined with Malathion.

Masoprocol


The risk or severity of adverse effects can be increased when Masoprocol is combined with Prednisone.

Meclofenamate


The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Prednisone.

Meclofenamic Acid


The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Prednisone.

Mefenamic Acid


The risk or severity of adverse effects can be increased when Mefenamic acid is combined with Prednisone.

Mefloquine


The risk or severity of adverse effects can be increased when Prednisone is combined with Mefloquine.

Meloxicam


The risk or severity of adverse effects can be increased when Meloxicam is combined with Prednisone.

Memantine


The risk or severity of adverse effects can be increased when Prednisone is combined with Memantine.

Mesalamine


The risk or severity of adverse effects can be increased when Mesalazine is combined with Prednisone.

Mesterolone


Prednisone may increase the fluid retaining activities of Mesterolone.

Mestranol


The serum concentration of Prednisone can be increased when it is combined with Mestranol.

Metergoline


The risk or severity of adverse effects can be increased when Metergoline is combined with Prednisone.

Metformin


The therapeutic efficacy of Metformin can be decreased when used in combination with Prednisone.

Methyclothiazide


Prednisone may increase the hypokalemic activities of Methyclothiazide.

Methyl Salicylate


The risk or severity of adverse effects can be increased when Methyl salicylate is combined with Prednisone.

Methylergonovine


The risk or severity of adverse effects can be increased when Methylergometrine is combined with Prednisone.

Methyltestosterone


Prednisone may increase the fluid retaining activities of Methyltestosterone.

Methysergide


The risk or severity of adverse effects can be increased when Methysergide is combined with Prednisone.

Metoclopramide


The risk or severity of adverse effects can be increased when Prednisone is combined with Metoclopramide.

Metolazone


Prednisone may increase the hypokalemic activities of Metolazone.

Mifepristone


The therapeutic efficacy of Prednisone can be decreased when used in combination with Mifepristone.

Miglitol


The therapeutic efficacy of Miglitol can be decreased when used in combination with Prednisone.

Miglustat


The therapeutic efficacy of Miglustat can be decreased when used in combination with Prednisone.

Minaprine


The risk or severity of adverse effects can be increased when Prednisone is combined with Minaprine.

Mitotane


The serum concentration of Prednisone can be decreased when it is combined with Mitotane.

Mivacurium


Mivacurium may increase the adverse neuromuscular activities of Prednisone.

MYCOPHENOLATE


The risk or severity of adverse effects can be increased when Mycophenolic acid is combined with Prednisone.

Mycophenolate Mofetil


The risk or severity of adverse effects can be increased when Mycophenolate mofetil is combined with Prednisone.

Mycophenolic Acid


The risk or severity of adverse effects can be increased when Mycophenolic acid is combined with Prednisone.

Nabumetone


The risk or severity of adverse effects can be increased when Nabumetone is combined with Prednisone.

Naftifine


The risk or severity of adverse effects can be increased when Naftifine is combined with Prednisone.

Nalidixic Acid


The risk or severity of adverse effects can be increased when Prednisone is combined with Nalidixic Acid.

Naloxegol


The serum concentration of Naloxegol can be increased when it is combined with Prednisone.

Nandrolone


Prednisone may increase the fluid retaining activities of Nandrolone.

Nandrolone Decanoate


Prednisone may increase the fluid retaining activities of Nandrolone decanoate.

Naproxen


The risk or severity of adverse effects can be increased when Naproxen is combined with Prednisone.

Natalizumab


The risk or severity of adverse effects can be increased when Prednisone is combined with Natalizumab.

Nateglinide


The therapeutic efficacy of Nateglinide can be decreased when used in combination with Prednisone.

Nefazodone


The serum concentration of Prednisone can be increased when it is combined with Nefazodone.

Nelfinavir


The serum concentration of Prednisone can be increased when it is combined with Nelfinavir.

Neostigmine


The risk or severity of adverse effects can be increased when Prednisone is combined with Neostigmine.

Nepafenac


The risk or severity of adverse effects can be increased when Nepafenac is combined with Prednisone.

Netupitant


The serum concentration of Prednisone can be increased when it is combined with Netupitant.

Nevirapine


The serum concentration of Prednisone can be decreased when it is combined with Nevirapine.

Nicergoline


The risk or severity of adverse effects can be increased when Nicergoline is combined with Prednisone.

Nicorandil


The risk or severity of adverse effects can be increased when Prednisone is combined with Nicorandil.

Niflumic Acid


The risk or severity of adverse effects can be increased when Niflumic Acid is combined with Prednisone.

Nilotinib


The metabolism of Prednisone can be decreased when combined with Nilotinib.

Nimesulide


The risk or severity of adverse effects can be increased when Nimesulide is combined with Prednisone.

Nintedanib


The serum concentration of Nintedanib can be increased when it is combined with Prednisone.

Norfloxacin


The risk or severity of adverse effects can be increased when Prednisone is combined with Norfloxacin.

O-PHENANTHROLINE


The risk or severity of adverse effects can be increased when Prednisone is combined with 1,10-Phenanthroline.

Ocrelizumab


Ocrelizumab may increase the immunosuppressive activities of Prednisone.

Oenothera biennis seed extract


The risk or severity of adverse effects can be increased when Evening primrose oil is combined with Prednisone.

Olaparib


The metabolism of Prednisone can be decreased when combined with Olaparib.

Olopatadine


The risk or severity of adverse effects can be increased when Olopatadine is combined with Prednisone.

Olsalazine


The risk or severity of adverse effects can be increased when Olsalazine is combined with Prednisone.

Osimertinib


The serum concentration of Prednisone can be increased when it is combined with Osimertinib.

Ouabain


Ouabain may decrease the cardiotoxic activities of Prednisone.

Ovine Digoxin Immune Fab


Digoxin Immune Fab (Ovine) may decrease the cardiotoxic activities of Prednisone.

Oxandrolone


Prednisone may increase the fluid retaining activities of Oxandrolone.

Oxaprozin


The risk or severity of adverse effects can be increased when Oxaprozin is combined with Prednisone.

Oxymetholone


Prednisone may increase the fluid retaining activities of Oxymetholone.

Oxyphenbutazone


The risk or severity of adverse effects can be increased when Oxyphenbutazone is combined with Prednisone.

Paclitaxel


The risk or severity of adverse effects can be increased when Paclitaxel is combined with Prednisone.

Palbociclib


The serum concentration of Prednisone can be increased when it is combined with Palbociclib.

Parecoxib


The risk or severity of adverse effects can be increased when Parecoxib is combined with Prednisone.

Parthenolide


The risk or severity of adverse effects can be increased when Parthenolide is combined with Prednisone.

Pazopanib


The serum concentration of Pazopanib can be increased when it is combined with Prednisone.

Pefloxacin


The risk or severity of adverse effects can be increased when Prednisone is combined with Pefloxacin.

Pentobarbital


The serum concentration of Prednisone can be decreased when it is combined with Pentobarbital.

Pergolide


The risk or severity of adverse effects can be increased when Pergolide is combined with Prednisone.

Phenformin


The therapeutic efficacy of Phenformin can be decreased when used in combination with Prednisone.

Phenobarbital


The serum concentration of Prednisone can be decreased when it is combined with Phenobarbital.

Phenylacetic Acid


The therapeutic efficacy of Phenylacetic acid can be decreased when used in combination with Prednisone.

Phenylbutazone


The risk or severity of adverse effects can be increased when Phenylbutazone is combined with Prednisone.

Phenylbutyrate


The therapeutic efficacy of Phenylbutyric acid can be decreased when used in combination with Prednisone.

Phenytoin


The serum concentration of Prednisone can be decreased when it is combined with Phenytoin.

Physostigmine


The risk or severity of adverse effects can be increased when Prednisone is combined with Physostigmine.

Pimecrolimus


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Prednisone.

Pioglitazone


The therapeutic efficacy of Pioglitazone can be decreased when used in combination with Prednisone.

Piretanide


Prednisone may increase the hypokalemic activities of Piretanide.

Pirfenidone


The risk or severity of adverse effects can be increased when Pirfenidone is combined with Prednisone.

Piroxicam


The risk or severity of adverse effects can be increased when Piroxicam is combined with Prednisone.

Piroxicam-Beta-Cyclodextrin


The risk or severity of adverse effects can be increased when Piroxicam is combined with Prednisone.

Pitavastatin


The serum concentration of Pitavastatin can be increased when it is combined with Prednisone.

Polyestradiol Phosphate


The serum concentration of Prednisone can be increased when it is combined with Polyestradiol phosphate.

Polythiazide


Prednisone may increase the hypokalemic activities of Polythiazide.

Posaconazole


The serum concentration of Prednisone can be increased when it is combined with Posaconazole.

Pramlintide


The therapeutic efficacy of Pramlintide can be decreased when used in combination with Prednisone.

Pravastatin


The serum concentration of Pravastatin can be increased when it is combined with Prednisone.

Primidone


The serum concentration of Prednisone can be decreased when it is combined with Primidone.

Promestriene


The serum concentration of Prednisone can be increased when it is combined with Promestriene.

Proscillaridin


Proscillaridin may decrease the cardiotoxic activities of Prednisone.

Pyridostigmine


The risk or severity of adverse effects can be increased when Prednisone is combined with Pyridostigmine.

Pyridostigmine Bromide


The risk or severity of adverse effects can be increased when Prednisone is combined with Pyridostigmine.

Quinestrol


The serum concentration of Prednisone can be increased when it is combined with Quinestrol.

Quinethazone


Prednisone may increase the hypokalemic activities of Quinethazone.

Rabies Immune Globulin, Human


The risk or severity of adverse effects can be increased when Prednisone is combined with Human rabies virus immune globulin.

Rabies Virus Vaccine Flury-Lep Strain


The therapeutic efficacy of Rabies virus inactivated antigen, A can be decreased when used in combination with Prednisone.

Ranolazine


The serum concentration of Ranolazine can be increased when it is combined with Prednisone.

Rapacuronium


Rapacuronium may increase the adverse neuromuscular activities of Prednisone.

Regular Insulin, Human


The therapeutic efficacy of Insulin Human can be decreased when used in combination with Prednisone.

Repaglinide


The therapeutic efficacy of Repaglinide can be decreased when used in combination with Prednisone.

Resveratrol


The risk or severity of adverse effects can be increased when Resveratrol is combined with Prednisone.

Rifabutin


The serum concentration of Prednisone can be decreased when it is combined with Rifabutin.

Rifampin


The serum concentration of Prednisone can be decreased when it is combined with Rifampicin.

Rifapentine


The serum concentration of Prednisone can be decreased when it is combined with Rifapentine.

Rifaximin


The serum concentration of Rifaximin can be increased when it is combined with Prednisone.

Rilpivirine


The serum concentration of Rilpivirine can be decreased when it is combined with Prednisone.

Ritonavir


The serum concentration of Prednisone can be increased when it is combined with Ritonavir.

Rivastigmine


The risk or severity of adverse effects can be increased when Prednisone is combined with Rivastigmine.

Rofecoxib


The risk or severity of adverse effects can be increased when Rofecoxib is combined with Prednisone.

Roflumilast


Roflumilast may increase the immunosuppressive activities of Prednisone.

Rosiglitazone


The therapeutic efficacy of Rosiglitazone can be decreased when used in combination with Prednisone.

Rosoxacin


The risk or severity of adverse effects can be increased when Prednisone is combined with Rosoxacin.

Rosuvastatin


The serum concentration of Rosuvastatin can be increased when it is combined with Prednisone.

ROTAVIRUS VACCINE, LIVE


The risk or severity of adverse effects can be increased when Prednisone is combined with Rotavirus Vaccine.

Rubella Virus Vaccine Live (wistar Ra 27-3 Strain)


The risk or severity of adverse effects can be increased when Prednisone is combined with Rubella virus vaccine.

Rucaparib


The metabolism of Prednisone can be decreased when combined with Rucaparib.

Salicylamide


The risk or severity of adverse effects can be increased when Salicylamide is combined with Prednisone.

Salicylic Acid


The risk or severity of adverse effects can be increased when Salicylic acid is combined with Prednisone.

Salmonella enterica subsp. enterica serovar typhi


The risk or severity of adverse effects can be increased when Prednisone is combined with Salmonella typhi ty21a live antigen.

Salsalate


The risk or severity of adverse effects can be increased when Salsalate is combined with Prednisone.

Saquinavir


The serum concentration of Prednisone can be increased when it is combined with Saquinavir.

Saquinavir Mesylate


The serum concentration of Prednisone can be increased when it is combined with Saquinavir.

Sarilumab


The therapeutic efficacy of Prednisone can be decreased when used in combination with Sarilumab.

Saxagliptin


The serum concentration of Saxagliptin can be decreased when it is combined with Prednisone.

Saxagliptin Anhydrous


The serum concentration of Saxagliptin can be decreased when it is combined with Prednisone.

Serratiopeptidase


The risk or severity of adverse effects can be increased when Serrapeptase is combined with Prednisone.

Sildenafil


The metabolism of Prednisone can be decreased when combined with Sildenafil.

Silodosin


The serum concentration of Silodosin can be increased when it is combined with Prednisone.

Siltuximab


The serum concentration of Prednisone can be decreased when it is combined with Siltuximab.

Simeprevir


The serum concentration of Prednisone can be increased when it is combined with Simeprevir.

Simvastatin


The serum concentration of Simvastatin can be increased when it is combined with Prednisone.

sipuleucel-T


The therapeutic efficacy of Sipuleucel-T can be decreased when used in combination with Prednisone.

Sitagliptin


The therapeutic efficacy of Sitagliptin can be decreased when used in combination with Prednisone.

Sitagliptin Phosphate


The therapeutic efficacy of Sitagliptin can be decreased when used in combination with Prednisone.

Sodium Bicarbonate


The bioavailability of Prednisone can be decreased when combined with Sodium bicarbonate.

Somatropin


The therapeutic efficacy of Prednisone can be decreased when used in combination with Somatotropin.

Sparfloxacin


The risk or severity of adverse effects can be increased when Prednisone is combined with Sparfloxacin.

ST. JOHN'S WORT EXTRACT


The serum concentration of Prednisone can be decreased when it is combined with St. John's Wort.

Stanozolol


Prednisone may increase the fluid retaining activities of Stanozolol.

Sulfasalazine


The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Prednisone.

Sulfisoxazole


The metabolism of Prednisone can be decreased when combined with Sulfisoxazole.

Sulindac


The risk or severity of adverse effects can be increased when Sulindac is combined with Prednisone.

Suprofen


The risk or severity of adverse effects can be increased when Suprofen is combined with Prednisone.

synthetic conjugated estrogens, A


The serum concentration of Prednisone can be increased when it is combined with Synthetic Conjugated Estrogens, A.

synthetic conjugated estrogens, B


The serum concentration of Prednisone can be increased when it is combined with Synthetic Conjugated Estrogens, B.

Tacrine


The risk or severity of adverse effects can be increased when Prednisone is combined with Tacrine.

Tacrolimus


Tacrolimus may increase the immunosuppressive activities of Prednisone.

Telaprevir


The serum concentration of Telaprevir can be decreased when it is combined with Prednisone.

Telithromycin


The serum concentration of Prednisone can be increased when it is combined with Telithromycin.

Temafloxacin


The risk or severity of adverse effects can be increased when Prednisone is combined with Temafloxacin.

Tenoxicam


The risk or severity of adverse effects can be increased when Tenoxicam is combined with Prednisone.

Teriflunomide


The risk or severity of adverse effects can be increased when Teriflunomide is combined with Prednisone.

Tesamorelin


The serum concentration of the active metabolites of Prednisone can be reduced when Prednisone is used in combination with Tesamorelin resulting in a loss in efficacy.

Testosterone


Prednisone may increase the fluid retaining activities of Testosterone.

Testosterone Cypionate


Prednisone may increase the fluid retaining activities of Testosterone cypionate.

Testosterone Enanthate


Prednisone may increase the fluid retaining activities of Testosterone enanthate.

Testosterone Propionate


Prednisone may increase the fluid retaining activities of Testosterone propionate.

Testosterone Undecanoate


Prednisone may increase the fluid retaining activities of Testosterone undecanoate.

Tetanus Toxoid Vaccine, Inactivated


The risk or severity of adverse effects can be increased when Prednisone is combined with Clostridium tetani toxoid antigen (formaldehyde inactivated).

Tiaprofenic Acid


The risk or severity of adverse effects can be increased when Tiaprofenic acid is combined with Prednisone.

Tibolone


The serum concentration of Prednisone can be increased when it is combined with Tibolone.

Ticlopidine


The metabolism of Prednisone can be decreased when combined with Ticlopidine.

Tocilizumab


The serum concentration of Prednisone can be decreased when it is combined with Tocilizumab.

Tofacitinib


Prednisone may increase the immunosuppressive activities of Tofacitinib.

Tolazamide


The therapeutic efficacy of Tolazamide can be decreased when used in combination with Prednisone.

Tolbutamide


The therapeutic efficacy of Tolbutamide can be decreased when used in combination with Prednisone.

Tolfenamic Acid


The risk or severity of adverse effects can be increased when Tolfenamic Acid is combined with Prednisone.

Tolmetin


The risk or severity of adverse effects can be increased when Tolmetin is combined with Prednisone.

Tolvaptan


The serum concentration of Tolvaptan can be increased when it is combined with Prednisone.

Topotecan


The serum concentration of Topotecan can be increased when it is combined with Prednisone.

Torsemide


Prednisone may increase the hypokalemic activities of Torasemide.

Tranilast


The risk or severity of adverse effects can be increased when Tranilast is combined with Prednisone.

Trastuzumab


Trastuzumab may increase the cardiotoxic activities of Prednisone.

Trichlormethiazide


Prednisone may increase the hypokalemic activities of Trichlormethiazide.

Troglitazone


The therapeutic efficacy of Troglitazone can be decreased when used in combination with Prednisone.

Trolamine Salicylate


The risk or severity of adverse effects can be increased when Trolamine salicylate is combined with Prednisone.

Tromethamine


The bioavailability of Prednisone can be decreased when combined with Tromethamine.

Trovafloxacin


The risk or severity of adverse effects can be increased when Prednisone is combined with Trovafloxacin.

Tubocurarine


The risk or severity of adverse effects can be increased when Prednisone is combined with Tubocurarine.

Typhoid Vaccine Live Ty21a


The risk or severity of adverse effects can be increased when Prednisone is combined with Salmonella typhi ty21a live antigen.

Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain


The risk or severity of adverse effects can be increased when Prednisone is combined with Salmonella typhi ty2 vi polysaccharide antigen.

Valdecoxib


The risk or severity of adverse effects can be increased when Valdecoxib is combined with Prednisone.

Varicella Virus Vaccine Live (Oka-Merck) strain


The risk or severity of adverse effects can be increased when Prednisone is combined with Varicella Zoster Vaccine (Live/Attenuated).

Vemurafenib


The serum concentration of Prednisone can be increased when it is combined with Vemurafenib.

Venlafaxine


The metabolism of Prednisone can be decreased when combined with Venlafaxine.

Verapamil


The metabolism of Prednisone can be decreased when combined with Verapamil.

Vildagliptin


The therapeutic efficacy of Vildagliptin can be decreased when used in combination with Prednisone.

Vincristine


The excretion of Vincristine can be decreased when combined with Prednisone.

Voriconazole


The serum concentration of Prednisone can be increased when it is combined with Voriconazole.

Warfarin


Prednisone may increase the anticoagulant activities of Warfarin.

Yellow Fever Vaccine


The risk or severity of adverse effects can be increased when Prednisone is combined with Yellow Fever Vaccine.

Yellow-Fever Virus Vaccine, 17D-204 strain


The risk or severity of adverse effects can be increased when Prednisone is combined with Yellow Fever Vaccine.

Zileuton


The risk or severity of adverse effects can be increased when Zileuton is combined with Prednisone.

Ziprasidone


The metabolism of Prednisone can be decreased when combined with Ziprasidone.

Zomepirac


The risk or severity of adverse effects can be increased when Zomepirac is combined with Prednisone.

Advertisement
Recommended Reading
Drugs A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
How to Live Longer and Healthier: Secrets of Longevity Revealed
Stay Connected
Available on the Android Market Available on the App Store

Home

Consult

e-Book

Articles

News

Calculators

Drugs

Directories

Education

Consumer

Professional